These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 21266263)

  • 21. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
    Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
    Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
    J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
    Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
    Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Complement System and Preeclampsia.
    Regal JF; Burwick RM; Fleming SD
    Curr Hypertens Rep; 2017 Oct; 19(11):87. PubMed ID: 29046976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of angiogenic factors in pre-eclampsia.
    Abimanyu B
    Pregnancy Hypertens; 2014 Jul; 4(3):246. PubMed ID: 26104650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-Based Revised View of the Pathophysiology of Preeclampsia.
    Ahmed A; Rezai H; Broadway-Stringer S
    Adv Exp Med Biol; 2017; 956():355-374. PubMed ID: 27873232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia.
    Pratt A; Da Silva Costa F; Borg AJ; Kalionis B; Keogh R; Murthi P
    Angiogenesis; 2015 Apr; 18(2):115-23. PubMed ID: 25433512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia.
    Iriyama T; Sun K; Parchim NF; Li J; Zhao C; Song A; Hart LA; Blackwell SC; Sibai BM; Chan LN; Chan TS; Hicks MJ; Blackburn MR; Kellems RE; Xia Y
    Circulation; 2015 Feb; 131(8):730-41. PubMed ID: 25538227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
    Silasi M; Cohen B; Karumanchi SA; Rana S
    Obstet Gynecol Clin North Am; 2010 Jun; 37(2):239-53. PubMed ID: 20685551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia.
    Kopcow HD; Karumanchi SA
    J Reprod Immunol; 2007 Dec; 76(1-2):23-9. PubMed ID: 17490755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular Sequels During and After Preeclampsia.
    Paauw ND; Lely AT
    Adv Exp Med Biol; 2018; 1065():455-470. PubMed ID: 30051401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes.
    Nezu M; Souma T; Yu L; Sekine H; Takahashi N; Wei AZ; Ito S; Fukamizu A; Zsengeller ZK; Nakamura T; Hozawa A; Karumanchi SA; Suzuki N; Yamamoto M
    Sci Signal; 2017 May; 10(479):. PubMed ID: 28512147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies.
    Umapathy A; Chamley LW; James JL
    Angiogenesis; 2020 May; 23(2):105-117. PubMed ID: 31707538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in understanding of preeclampsia.
    Bdolah Y; Karumanchi SA; Sachs BP
    Croat Med J; 2005 Oct; 46(5):728-36. PubMed ID: 16158464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.